Skip to content. | Skip to navigation

Personal tools

Sections
You are here: Home / Teams / Functional genomics of thyroid signaling - F. FLAMANT / Publications / publications-flamant / Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease

Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease

B. Finan, C. Clemmensen, Z. Zhu, K. Stemmer, K. Gauthier, L. Muller, M. De Angelis, K. Moreth, F. Neff, D. Perez-Tilve, K. Fischer, D. Lutter, M. A Sanchez-Garrido, P. Liu, J. Tuckermann, M. Malehmir, M. E Healy, A. Weber, M. Heikenwalder, M. Jastroch, M. Kleinert, S. Jall, S. Brandt, F. Flamant, K. W Schramm, H. Biebermann, Y. Doring, C. Weber, K. M Habegger, M. Keuper, V. Gelfanov, F. Liu, J. Kohrle, J. Rozman, H. Fuchs, V. Gailus-Durner, M. Hrabe de Angelis, S. M Hofmann, B. Yang, M. H Tschop, R. DiMarchi, and T. D Muller (2016)

Cell, 167(3):843-857 e14.

Document Actions